Related Experiment Videos
Cyclooxygenase blockade limits blood flow to collateral-dependent myocardium during exercise
J D Altman1, C L Klassen, R J Bache
1Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.
Cardiovascular Research
|November 1, 1995
Summary
Cyclooxygenase blockade, using indomethacin, constricts coronary collateral vessels. This impairs blood flow to the heart muscle during exercise, highlighting a risk for patients with coronary artery disease.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Myocardial Ischemia Research
Background:
- Cyclooxygenase (COX) blockade is known to induce coronary collateral vasoconstriction in animal models.
- Understanding the impact of COX blockade on collateral-dependent myocardium during physiological stress like exercise is crucial.
Purpose of the Study:
- To investigate whether cyclooxygenase blockade limits blood flow to collateral-dependent heart muscle during exercise.
- To assess the effects of indomethacin on coronary collateral function and myocardial perfusion.
Main Methods:
- Conducted studies in 8 adult mongrel dogs with induced collateral-dependent myocardium.
- Measured myocardial blood flow using radioactive microspheres at rest and during treadmill exercise.
- Administered indomethacin (5 mg/kg i.v.) to assess its effects on coronary hemodynamics and flow.
Main Results:
- Indomethacin significantly increased the aortic-to-distal coronary pressure gradient and transcollateral resistance during exercise.
- A 27% decrease in subendocardial flow within the collateral-dependent zone was observed post-indomethacin.
- No significant changes in normal zone blood flow or subepicardial collateral zone flow occurred.
Conclusions:
- Cyclooxygenase blockade causes coronary collateral vasoconstriction in intact, awake animals.
- This vasoconstriction can impair blood flow to the myocardium dependent on collateral circulation, particularly during exercise.
- Findings suggest potential risks of COX inhibitors in patients with compromised coronary circulation.